LEA TRIPODI: Open Payments
NPI 1871230573 · MANCHESTER, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 81 payments from 15 companies in 2025. Trend: 2023 $4,487 · 2024 $3,388 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $510 |
| Novartis Pharmaceuticals Corporation | 15 | $147 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| Genentech USA, Inc. | 5 | $106 |
| Mallinckrodt Hospital Products Inc. | 3 | $87 |
| Amgen Inc. | 3 | $63 |
| Janssen Biotech, Inc. | 1 | $57 |
| GlaxoSmithKline, LLC. | 2 | $55 |
| Organon LLC | 3 | $49 |
| UCB, Inc. | 2 | $37 |
Products named: RINVOQ, SKYRIZI, COSENTYX, SAPHNELO, Actemra, ACTHAR, EVENITY, TREMFYA.
Industry payments across CT — which companies pay providers there.
